Authors: Shao Yi, He Liangqi, Yang Qichen DOI: 10.3760/cma.j.cn115989-20250212-00035 Published: 2025 -09 -10 Citation Shao Yi, He Liangqi, Yang Qichen. Interpretation of the Consensus Document for Management of Retinoblastoma by India Council for Medical Research[J]. Chin J Exp Ophthalmol, 2025, 43(9):839-845. DOI: 10.3760/cma.j.cn115989-20250212-00035. ABSTRACT [Download PDF] [View Full Text] Retinoblastoma […]
Tag: Retinoblastoma
Effect of LncRNA LUCAT1 targeting miR-502-5p on the biological behavior of human retinoblastoma cells
Authors: Xing Feng, Li Yongming, Gao Mingmin DOI: 10.3760/cma.j.cn115989-20210826-00481 Published 2023-04-10 Cite as Chin J Exp Ophthalmol, 2023, 41(4): 321-329. Abstract [Download PDF] [Read Full Text] Objective To investigate the effects of long noncoding RNA (LncRNA) lung cancer associated transcript 1 (LUCAT1) […]
Are you ready? The new era of targeted local chemotherapy for retinoblastoma is coming
Authors: Chen Danian, Gao Jingge DOI: 10.3760/cma.j.issn.2095-0160.2015.11.001 Published 2015-11-10 Cite as Chin J Exp Ophthalmol, 2015,33(11): 961-964. Abstract [Download PDF] [Read Full Text] Retinoblastoma (RB) therapy has evolved over decades.In the 1970s, enucleation was important for improving life prognosis.In the 1980s, external […]
Comparison of clinical outcomes of ophthalmic artery chemotherapy with systemic vein-eye artery chemotherapy for retinoblastoma in children
·Clinical Research· Comparison of the clinical outcomes of ophthalmic artery chemotherapy with systemic vein-eye artery chemotherapy for retinoblastoma in children Di Qi1, Shen Gang2, Shi Shengli1, Lu Yuebing1, Zhang Jing3, Liu Jing1, Hu Jing1, Chen Zhiping1 1Department of Radiology, Chidren’s Hospital Affiliated of Zhengzhou University, Henan Children’s Hospital, Zhengzhou 450018, China; 2Interventional Hemangioma Department, Children’s […]
Inhibitory effects of lncRNA ADPGK-AS1 on the biological behaviours of human retinoblastoma cells and its regulating mechanism
Authors: Zhang Jun, Liu Cailin, Bu Zhanyun DOI: 10.3760/cma.j.cn115989-20200819-00599 Published 2021-03-10 Cite as Chin J Exp Ophthalmol, 2021, 39(3): 207-215. Abstract [View PDF] [Read Full Text] Objective To explore the effects of long noncoding RNA adenosine diphosphate-dependent glucokinase antisense RNA 1(ADPGK-AS1) […]
Controversy of vitrectomy in the treatment of intraocular malignancy
Authors: Gao Jingge, Chen Danian DOI: 10.3760/cma.j.cn115989-20200311-00165 Published 2021-03-10 Cite as Chin J Exp Ophthalmol, 2021, 39(3): 249-253. Abstract [View PDF] [Read Full Text] […]
A systematic review of the efficiency and safety of intra-arterial chemotherapy for retinoblastoma
Authors：Gao Jingge, Chen Danian DOI: 10.3760/cma.j.issn.2095-0160.2016.11.015 Published 2016-11-10 Cite as Chin J Exp Ophthalmol, 2016,34(11): 1031-1037. Abstract [Download PDF] [Read Full Text] Background Retinoblastoma (RB) is the most common primary ocular malignancy in children.Many treatment modalities have been applied to RB.As an exciting option to reduce systemic adverse effects and […]
Gene research progress of retinoblastoma
Authors: Yu Tian, Chen Changzheng, Xing Yiqiao DOI: 10.3760/cma.j.issn.2095-0160.2017.08.019 Published 2017-08-10 Cite as Chin J Exp Ophthalmol, 2017,35(8): 756-760. Abstract [Download PDF] [Read Full Text] Retinoblastoma (RB) is a common intraocular malignant tumor of infants.It not only seriously threats children’s eyesight, but also endangers their lives.RB develops from […]
Emphasizing on the importance of RB1 genetic testing in diagnosis/treatment and genetic counseling of retinoblastoma
Authors: Chen Danian, Fan Yimeng DOI: 10.3760/cma.j.issn.2095-0160.2018.10.002 Published 2018-10-10 Cite as Chin J Exp Ophthalmol, 2018,36(10): 742-747. Abstract [Download PDF] [Read Full Text] Retinoblastoma (RB) is the prototype of hereditary neoplasms in humans.It is the most common intraocular malignancy in children, which is mainly caused by RB1 […]